loxiglumide has been researched along with Obesity, Morbid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeckxstaens, GE; D'Amato, M; Fakhry, N; Hirsch, DP; Holloway, RH; Mathus-Vliegen, EM | 1 |
1 trial(s) available for loxiglumide and Obesity, Morbid
| Article | Year |
|---|---|
Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects.
Topics: Adult; Esophagogastric Junction; Hormone Antagonists; Humans; Manometry; Middle Aged; Obesity, Morbid; Postprandial Period; Proglumide; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 2002 |